These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38842589)

  • 1. Facilitators and barriers to adopting or expanding medications for opioid use disorder provision in rural Colorado jails: a qualitative analysis.
    McNeely HL; Schreiber TL; Swann WL; Amura CR
    Health Justice; 2024 Jun; 12(1):26. PubMed ID: 38842589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jail-based treatment for opioid use disorder in the era of bail reform: a qualitative study of barriers and facilitators to implementation of a state-wide medication treatment initiative.
    Krawczyk N; Bandara S; Merritt S; Shah H; Duncan A; McEntee B; Schiff M; Ahmad NJ; Whaley S; Latimore A; Saloner B
    Addict Sci Clin Pract; 2022 Jun; 17(1):30. PubMed ID: 35655293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
    Harrington C; Bailey A; Delorme E; Hano S; Evans EA
    Subst Use Misuse; 2023; 58(2):266-274. PubMed ID: 36510800
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors Associated With the Availability of Medications for Opioid Use Disorder in US Jails.
    Flanagan Balawajder E; Ducharme L; Taylor BG; Lamuda PA; Kolak M; Friedmann PD; Pollack HA; Schneider JA
    JAMA Netw Open; 2024 Sep; 7(9):e2434704. PubMed ID: 39316401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability of best practices for opioid use disorder in jails and related training and resource needs: findings from a national interview study of jails in heavily impacted counties in the U.S.
    Scott CK; Grella CE; Dennis ML; Carnevale J; LaVallee R
    Health Justice; 2022 Dec; 10(1):36. PubMed ID: 36538121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder.
    Benck KN; Seide K; Jones AK; Omori M; Rubinstein LB; Beckwith C; Nowotny KM
    Drug Alcohol Depend; 2023 Jun; 247():109863. PubMed ID: 37071946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation.
    Pourtaher E; Gelberg KH; Fallico M; Ellendon N; Li S
    J Subst Use Addict Treat; 2024 Jun; 161():209248. PubMed ID: 38081540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.
    Stopka TJ; Rottapel RE; Ferguson WJ; Pivovarova E; Toro-Mejias LD; Friedmann PD; Evans EA
    Int J Drug Policy; 2022 Dec; 110():103803. PubMed ID: 35965159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Availability of Medications for the Treatment of Opioid Use Disorder Among Pregnant and Postpartum Individuals in US Jails.
    Sufrin C; Kramer CT; Terplan M; Fiscella K; Olson S; Voegtline K; Latkin C
    JAMA Netw Open; 2022 Jan; 5(1):e2144369. PubMed ID: 35050354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.
    Matsumoto A; Santelices C; Evans EA; Pivovarova E; Stopka TJ; Ferguson WJ; Friedmann PD
    Int J Drug Policy; 2022 Nov; 109():103823. PubMed ID: 35994938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives.
    Michener PS; Evans EA; Ferguson WJ; Friedmann PD
    Addict Sci Clin Pract; 2024 Feb; 19(1):10. PubMed ID: 38347634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).
    Evans EA; Stopka TJ; Pivovarova E; Murphy SM; Taxman FS; Ferguson WJ; Bernson D; Santelices C; McCollister KE; Hoskinson R; Lincoln T; Friedmann PD;
    J Subst Abuse Treat; 2021 Sep; 128():108275. PubMed ID: 33483222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing provision of MOUD and obstetric care in U.S. jails: A content analysis of policies submitted by 59 jails.
    Kao L; Lee C; Parayil T; Kramer C; Sufrin CB
    Drug Alcohol Depend; 2023 Jul; 248():109877. PubMed ID: 37244223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Access to Services for Pregnant People With Opioid Use Disorder in Jails in the United States.
    Grella CE; Scott CK; Dennis ML; LaVallee RA
    J Correct Health Care; 2023 Aug; 29(4):299-307. PubMed ID: 37252747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers.
    Pivovarova E; Taxman FS; Boland AK; Smelson DA; Lemon SC; Friedmann PD
    J Subst Use Addict Treat; 2023 Apr; 147():208950. PubMed ID: 36804347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts.
    Evans EA; Pivovarova E; Senthilkumar R; Rottapel RE; Stopka TJ; Santelices C; Ferguson WJ; Friedmann PD
    Int J Drug Policy; 2023 Dec; 122():104252. PubMed ID: 37980776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives.
    Pivovarova E; Evans EA; Stopka TJ; Santelices C; Ferguson WJ; Friedmann PD
    Drug Alcohol Depend; 2022 May; 234():109394. PubMed ID: 35349918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail.
    Evans EA; Pivovarova E; Stopka TJ; Santelices C; Ferguson WJ; Friedmann PD
    J Subst Abuse Treat; 2022 Jul; 138():108746. PubMed ID: 35249789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Get It in Writing: How to Make Medications for Opioid Use Disorder Available During Incarceration.
    McGladrey M; Kelsch J; Lofwall MR; Fanucchi LC; Walsh SL; Oser CB
    J Correct Health Care; 2024 Feb; 30(1):3-6. PubMed ID: 38150232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to treatment for pregnant incarcerated people with opioid use disorder: Perspectives from community opioid treatment providers.
    King Z; Kramer C; Latkin C; Sufrin C
    J Subst Abuse Treat; 2021 Jul; 126():108338. PubMed ID: 34116823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.